WNT5A and breast cancer: Additionally, further studies are required for the development of new drugs targeting drug resistance markers; for instance, the development of a treatment strategy for Wnt5a-positive breast cancer based on anti-Wnt5a antibodies, in line with that developed for Wnt5a-positive gastric cancer [33] should be carried out.